Demo

8240 Articles Matching "drug"

FDA Approves First Drug Aimed at Preventing Migraines

May 20, 2018 , MedicineNet
Title: FDA Approves First Drug Aimed at Preventing MigrainesCategory: Health NewsCreated: 5/18/2018 12:00:00 AMLast Editorial Review: 5/18/2018 12:00:00...
Read more

FDA Approves First Non-Opioid for Withdrawal

May 20, 2018 , RxList
The FDA approved the first non-opioid drug, lofexidine hydrochloride (Lucemyra), to help treat symptoms of opioid withdrawal in...
Read more

Commentary: Trump's proposals on drug prices are right to focus on anti-competitive market practices

May 19, 2018 , Modern Healthcare Breaking News
There are proposals in President Donald Trump plan that if implemented could ensure stronger competition from generic and biosimilar medicines and thereby increase access and provide financial relief for patients at the pharmacy...
Read more

Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst

May 19, 2018 , CNBC Health
Aimovig from Amgen and Novartis may become a $1 billion to $2 billion business in five years, say a Wall Street...
Read more

FDA names and shames drug makers to encourage generic competition

May 19, 2018 , CNBC Health
Major pharmaceutical companies have spent billions of dollars in an effort to patent their products and avoid generic copies of blockbuster medicines, but the FDA commissioner has vowed to end this, the New York Times reports....
Read more
Demo

Johnson & Johnson scraps Alzheimer's drug trials on safety concerns

May 19, 2018 , CNBC Health
Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's...
Read more

Most Americans Think The Opioid Epidemic Is A Problem — Just Not One That’s In Their Backyard

May 19, 2018 , Kaiser Health News
Less than a quarter of the people surveyed feel it's an emergency in their community, U.S. Surgeon General Jerome Adams said. In other news on the crisis: the FDA criticizes a big data provider over a mistake concerning the amount of fentanyl prescribed over the past year; Sen. Claire McCaskill (D-Mo.) wants information on steps a drugmaker has taken to mitigate the opioid epidemic; a House panel advances a package of bills dealing with the epidemic; and more....
Read more

U.S. agency rescinds order banning Louisiana distributor from opioid sales

May 19, 2018 , Reuters
WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration on Friday reversed an order that halted a Louisiana drug wholesaler's opioid sales over allegations it failed to report suspiciously large orders by pharmacies for the narcotics, court documents showed....
Read more

Study Shows Breast Cancer Treatment Can Be Cut In Half: There’s No Longer A ‘Need To Throw The Kitchen Sink At It’

May 18, 2018 , Kaiser Health News
Typically, Herceptin is used for a year to treat breast cancer patients, but a new study finds it is effective with six months of use. The drug can damage the heart, and so a shorter amount of time taking it can improve patients' long-term health outcomes....
Read more

FDA names drugmakers potentially acting to delay cheap generics

May 18, 2018 , Reuters
(Reuters) - The U.S. Food and Drug Administration on Thursday listed a number of drugmakers it said could be improperly blocking access to their medicines in order to delay generic competition....
Read more

Shorter breast cancer treatment could hurt providers' pockets

May 18, 2018 , Modern Healthcare Breaking News
Women who use the breast cancer drug Herceptin for six months did just as well as those who took it for a year, according to a new study that could ultimately benefit value-based providers and harm those still based on fee-for-service...
Read more
Cardon Children's Medical Center

Discount Drug Mart taps McKesson HVS system for central fill pharmacy

May 18, 2018 , Drug Store News - Clinical Retail
McKesson High Volume Solutions (HVS) will provide a dispensing automation platform for Discount Drug Mart’s central fill pharmacy to be located in Avon Lake, Ohio, the company has announced. Read More...
Read more

FDA approves first non-opioid treatment for opioid withdrawal

May 18, 2018 , Drug Store News - Clinical Retail
The U.S. Food and Drug Administration has approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for management of opioid withdrawal symptoms in adults. Read More...
Read more

Research Roundup: Prescription For Drug Reform; Sexual Orientation and Depression in Adolescents

May 18, 2018 , Kaiser Health News
Each week, KHN compiles a selection of recently released health policy studies and...
Read more

Viewpoints: Trump’s Ideas On Prescription Drug Prices Put Patients Last; EPA Fails Duty To Report Real News On Water Quality

May 18, 2018 , Kaiser Health News
Editorial writers focus on these and other health...
Read more

Perspectives: Drug Policies On Opioid Prescriptions Fall Short; Why Jack Up Costs Of Life-Saving Naloxone?

May 18, 2018 , Kaiser Health News
Opinion writers weigh in on health topics surrounding the opioid...
Read more

There’s Still Little Proof To Back Up Hype Over Combination Cancer Immunotherapies

May 18, 2018 , Kaiser Health News
All the buzz over combining experimental immune-boosting drugs with checkpoint inhibitors could fizzle into disappointment. In other public health news: eye treatments, aging athletes, the E. coli outbreak, hearing aids, and Ebola....
Read more

FDA approves new Amgen drug for prevention of migraines

May 18, 2018 , CNBC Health
Amgen won FDA approval on Thursday for the first drug to prevent migraine headaches in...
Read more

U.S. FDA approves Amgen drug for prevention of migraines

May 18, 2018 , Reuters
(Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults....
Read more

FDA Approves First Non-Opioid for Withdrawal

May 18, 2018 , WebMD
The FDA found the drug to be safe and effective in easing symptoms such as diarrhea, nausea, vomiting, anxiety, and an overall feeling of sickness that often keep patients from withdrawing from...
Read more